Hyperphosphorylation of autophosphorylation site tyrosine in FYN was detected in protein tyrosine phosphatase N23 (PTPN23)-deficient breast cancer tumors, confirming that FYN could be a therapeutic target for PTPN23 heterozygous or pure deletion breast tumors [62]. Here, PTPN23 is linked to breast neoplasm.